Please login to the form below

Not currently logged in
Email:
Password:

C4X Discovery appoints chief executive officer

Executive chairman Clive Dix takes on the lead role

C4X Discovery Clive DixManchester, UK-based drug discovery and development company C4X Discovery has appointed Clive Dix as its new chief executive officer.

Dix will take on his new role immediately, relinquishing his previous role as the firm's executive chairman.

He joined C4X Discovery in 2014 as non-executive chairman, bringing over 30 years of experience in the pharmaceutical and biotechnology industries to the firm.

Since joining GlaxoSmithKline's research department in 1988, Dix has held a series of senior leadership positions including chief executive officer of Convergence Pharmaceuticals and chairman of both Crescendo Biologics and Modern Biosciences.

In addition to his new role at C4X Discovery, Dix also serves as chairman of Calchan Limited, Centauri Therapeutics and Touchlight Genetics.

Dix said: “Having seen from an executive position the potential of the platform to generate entirely new compounds against high-value therapeutic targets more rapidly and efficiently than any technology I've come across before and having witnessed the interest we're receiving in C4X Discovery, I am delighted to take the helm on a full-time basis.

“I have never been more excited by a company than this one.”

6th May 2016

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

Here at Cuttsy+Cuttsy, we believe in making the world a better place by bringing trusted, accessible information to all and...

Latest intelligence

Biosimilars and beyond: innovating for improved patient outcomes
How Europe’s biosimilar landscape has rapidly evolved over the last two decades, bringing biological medicines to more patients than ever before...
World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...